Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release cisplatin implant for portal vein tumor thrombus in advanced hepatocellular carcinoma
CTR20132935Phase 3Suspended
- Sponsor
- Anhui Zhongren Technology
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in hepatocellular carcinoma (HCC), portal vein tumor thrombosis (PVTT), sponsored by Anhui Zhongren Technology. Started Feb 2014; status: suspended.
02
Drugs
cisplatin
03
Conditions
hepatocellular carcinoma (HCC)portal vein tumor thrombosis (PVTT)
Beyond the preview
Go deeper on CTR20132935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132935.